文献速递泌尿系结石

COVID-19对英国输尿管结石管理和结局的影响:一项多中心回顾性研究

Impact of COVID-19 on the management and outcomes of ureteric stones in the UK: a multicentre retrospective study.
PubMed 文献 · BJU Int · 2022-10-19

该多中心回顾性研究纳入英国39家医院3735例CT确诊的输尿管结石成人患者,比较疫情前(1956例)与疫情期间(1779例)的管理与结局。疫情期间住院率更低、住院时间更短、药物排石治疗更多,介入治疗中体外冲击波碎石和肾造瘘更多而输尿管镜、支架置入和全身麻醉更少。两组主要治疗方式成功率无差异(疫情前73.8% vs 疫情时76.1%,P=0.11),手术并发症、30天死亡率、再入院和6个月肾功能也无差异。

要点

  • 疫情期间住院率更低(54.0% vs 46.5%,P<0.001),住院时间更短(4.1 vs 3.3天,P=0.02)。
  • 介入治疗中体外冲击波碎石(22.7% vs 34.1%,P<0.001)和肾造瘘(7.1% vs 10.5%,P=0.03)比例更高。
  • 主要治疗方式成功率无差异(73.8% vs 76.1%,P=0.11),并发症和30天死亡率无差异。

核心结论

  • COVID-19疫情期间输尿管结石患者住院率和侵入性操作减少,但治疗成功率和结局无差异。
  • 作者认为临床医生可以安全地采用疫情期间发展的管理策略,以更保守的方式在社区治疗更多患者。

研究设计与样本

  • 多中心回顾性研究,纳入英国39家医院CT确诊的输尿管结石成人患者。
  • 比较疫情前(2019年3月23日至2019年6月22日)与疫情期间(各中心首例SARS-CoV-2病例后3个月)两个时段。
  • 共纳入3735例患者,疫情前1956例,疫情期间1779例。
  • 主要结局为主要治疗方式的成功,定义为无需针对原输尿管结石进一步治疗。

主要发现

  • 两组结石大小相似(P>0.05)。
  • 疫情期间住院率更低(疫情前54.0% vs 疫情时46.5%,P<0.001),平均住院时间更短(4.1 vs 3.3天,P=0.02),药物排石治疗使用率更高(17.4% vs 25.4%,P<0.001)。
  • 接受介入治疗的患者中(疫情前787例 vs 疫情时685例),体外冲击波碎石率更高(22.7% vs 34.1%,P<0.001),肾造瘘率更高(7.1% vs 10.5%,P=0.03)。
  • 接受介入治疗的患者中,输尿管镜率更低(57.2% vs 47.5%,P<0.001),支架置入率更低(68.4% vs 54.6%,P<0.001),全身麻醉率更低(92.2% vs 76.2%,P<0.001)。
  • 主要治疗方式成功率无差异(疫情前73.8% vs 疫情时76.1%,P=0.11),按治疗方式或结石大小分层后也无差异;手术并发症、30天死亡率、再入院和6个月肾功能在两个数据收集时段无差异。

临床怎么用

  • 作者认为临床医生可以安全地采用疫情期间发展的管理策略,以更保守的方式在社区治疗更多患者。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To determine if management of ureteric stones in the UK changed during the coronavirus disease 2019 (COVID-19) pandemic and whether this affected patient outcomes. PATIENTS AND METHODS: We conducted a multicentre retrospective study of adults with computed tomography-confirmed ureteric stone disease at 39 UK hospitals during a pre-pandemic period (23/3/2019-22/6/2019) and a period during the pandemic (the 3-month period after the first severe acute respiratory syndrome coronavirus-2 case at individual sites). The primary outcome was success of primary treatment modality, defined as no further treatment required for the index ureteric stone. Our study protocol was published prior to data collection. RESULTS: A total of 3735 patients were included (pre-pandemic 1956 patients; pandemic 1779 patients). Stone size was similar between groups (P > 0.05). During the pandemic, patients had lower hospital admission rates (pre-pandemic 54.0% vs pandemic 46.5%, P < 0.001), shorter mean length of stay (4.1 vs 3.3 days, P = 0.02), and higher rates of use of medical expulsive therapy (17.4% vs 25.4%, P < 0.001). In patients who received interventional management (pre-pandemic 787 vs pandemic 685), rates of extracorporeal shockwave lithotripsy (22.7% vs 34.1%, P < 0.001) and nephrostomy were higher (7.1% vs 10.5%, P = 0.03); and rates of ureteroscopy (57.2% vs 47.5%, P < 0.001), stent insertion (68.4% vs 54.6%, P < 0.001), and general anaesthetic (92.2% vs 76.2%, P < 0.001) were lower. There was no difference in success of primary treatment modality between patient cohorts (pre-pandemic 73.8% vs pandemic 76.1%, P = 0.11), nor when patients were stratified by treatment modality or stone size. Rates of operative complications, 30-day mortality, and re-admission and renal function at 6 months did not differ between the data collection periods. CONCLUSIONS: During the COVID-19 pandemic, there were lower admission rates and fewer invasive procedures performed. Despite this, there were no differences in treatment success or outcomes. Our findings indicate that clinicians can safely adopt management strategies developed during the pandemic to treat more patients conservatively and in the community.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Byrne MHV, Georgiades F, Light A, et al. Impact of COVID-19 on the management and outcomes of ureteric stones in the UK: a multicentre retrospective study. BJU Int. 2022. PMID: 36083711. doi:10.1111/bju.15882

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。